: The maker of Invisalign rose 131% as clear aligners began capturing a massive share of the dental market. Blue-Chip and Large-Cap Winners
The year 2017 was a landmark year for equity markets, characterized by a massive surge in and semiconductors . While the tech giants of the "FANG" era (Facebook, Amazon, Netflix, Google) continued to post impressive gains, the true "breakout" stories came from specialized medical research and the chips powering the digital revolution. The Best Performing Stocks of 2017 top stocks to buy 2017
The top of the leaderboard was dominated by small-to-mid-cap biotechnology firms that saw astronomical returns following clinical trial successes or major partnerships. : The maker of Invisalign rose 131% as
: Returned 373% after receiving FDA approval for its hepatitis B vaccine. The Best Performing Stocks of 2017 The top
For more conservative investors, the major indices also provided significant "win" stories through well-known household names.
: Gained 387% due to positive developments in its painkiller and immuno-oncology portfolio.